Humanized Matrix for Organoid: Personalized Anti-Cancer Drug Screening

With aging, the occurrence of cancer increases, and a precise anti-cancer drug screening greatly benefits patients and healthcare system. With aging the tissue repairing ability also declines. The biomaterials help tissue repairing will be the core of next generation medical devices. GEcoll combines Large Segment (LS) gene editing technology and synthetic biology platforms to develop humanized extracellular matrix for humanized in vitro microenvironment. Our humanized in vitro microenvironment can be used in the fields of personalized anti-cancer drug screening and tissue repairing and regeneration. GEcoll meets the needs of personal precision medicine.

1. Really mimic the microenvironment of human tissue

Using humanized extracellular matrix to create a human version of microenvironment

2. Stable quality/sustainable environmental protection

Using synthetic rice biological platform to mass-produce humanized bio-matrix with high biological activity and physiological function and bio-risk free.

3. Fast/easy to operate

Obtaining the results of anti-cancer drug screening within 2 weeks.

 Look for: 

Agents/distributors, CRO and LDT diagnostic center.

 InnoZone Booth No. A108